RWM
PTLA

Raffa Wealth Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Raffa Wealth Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-31
Closed -$841 – 807
2019
Q2 		$841 Buy
+31
New +$972 ﹤0.01% 703

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Raffa Wealth Management's PTLA Position: Q3 2019 in Review

Raffa Wealth Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2019, closing a stake of 31 shares — an estimated $841 sold.

Raffa Wealth Management first reported a position in PTLA in Q2 2019 and held it in 1 quarter. The position peaked at $841 in Q2 2019. 212 funds tracked by Wall St. Rank hold PTLA as of Q3 2019.

  • Raffa Wealth Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Raffa Wealth Management sold 31 Portola Pharmaceuticals, Inc. shares in Q3 2019, an estimated $841.
  • Raffa Wealth Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2019 and held it in 1 quarter.
  • Raffa Wealth Management's Portola Pharmaceuticals, Inc. position peaked at $841 in Q2 2019.
  • 212 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2019.

Based on Raffa Wealth Management's 13F filing for Q3 2019, filed 27 Jul 2026.